Lars Dölken
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Molecular Biology top 2%
- RNA Research and Splicing
- Genomics and Chromatin Dynamics
- RNA and protein synthesis mechanisms
Papers in
- Epidemiology 44
- Cytomegalovirus and herpesvirus research 28
- Herpesvirus Infections and Treatments 13
-
- SARS-CoV-2 and COVID-19 Research 10
- SARS-CoV-2 detection and testing 9
- Co-authors
- Florian Erhard (32 shared papers)Caroline C. Friedel (24 shared papers)Ralf Zimmer (10 shared papers)Ulrich Helmut Koszinowski (14 shared papers)Zsolt Ruzsics (14 shared papers)Thomas Hennig (23 shared papers)Sébastien Pfeffer (6 shared papers)Lisa Marcinowski (5 shared papers)
- Journals
- Journal of Virology (12 papers)PLoS Pathogens (8 papers)Nature Communications (7 papers)PLoS ONE (5 papers)Viruses (5 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Lars Dölken
116 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 573
- Molecular Biology 2.6k
- Immunology 692
- Epidemiology 889
- Infectious Diseases 472
Countries citing papers authored by Lars Dölken
This map shows the geographic impact of Lars Dölken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Dölken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Dölken more than expected).
Fields of papers citing papers by Lars Dölken
This network shows the impact of papers produced by Lars Dölken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Dölken. The network helps show where Lars Dölken may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Dölken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 322 | |
| 2 | 2011 | 289 | |
| 3 | 2020 | 252 | |
| 4 | 2013 | 231 | |
| 5 | 2015 | 210 | |
| 6 | 2009 | 179 | |
| 7 | 2010 | 172 | |
| 8 | 2019 | 163 | |
| 9 | 2012 | 160 | |
| 10 | 2018 | 158 | |
| 11 | 2010 | 132 | |
| 12 | 2010 | 130 | |
| 13 | 2021 | 124 | |
| 14 | 2016 | 108 | |
| 15 | 2013 | 104 | |
| 16 | 2020 | 101 | |
| 17 | 2015 | 98 | |
| 18 | 2013 | 93 | |
| 19 | 2013 | 81 | |
| 20 | 2018 | 78 |
About Lars Dölken
Lars Dölken is a scholar working on Epidemiology, Infectious Diseases, Immunology, Molecular Biology and Cancer Research, having authored 120 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (28 papers), RNA Research and Splicing (19 papers), Herpesvirus Infections and Treatments (13 papers), Genomics and Chromatin Dynamics (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers), SARS-CoV-2 detection and testing (9 papers), interferon and immune responses (7 papers) and RNA and protein synthesis mechanisms (6 papers). The work is most often cited by research in Cancer Research (573 citations), Molecular Biology (2.6k citations), Immunology (692 citations), Epidemiology (889 citations) and Infectious Diseases (472 citations). Lars Dölken has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Florian Erhard, Caroline C. Friedel, Ralf Zimmer, Ulrich Helmut Koszinowski, Zsolt Ruzsics, Thomas Hennig, Sébastien Pfeffer, Lisa Marcinowski, Christopher Jürges and Anne L’Hernault. Their work appears in journals such as Journal of Virology, PLoS Pathogens, Nature Communications, PLoS ONE and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.